The nation’s widespread racial health disparities won’t be erased without changes to how health care systems are funded and accredited, more public and financial accountability
When Timothy Yu developed milasen, a custom drug for a young girl named Mila with Batten disease, he ignited a spark in the field of
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The European Commission on Wednesday
Dive Brief: Tandem Diabetes Care has received 510(k) clearance for its Mobi insulin pump, a smaller durable pump that can be controlled from a smartphone.
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The U.S. Food and Drug
Dive Brief: Megadyne’s recall of electrode pads was classified by the U.S. Food and Drug Administration as a Class I event due to the risk of
The proposed new payment method to address antimicrobial resistance involves a fixed annual ‘subscription-style’ fee as opposed to a sum based on how many prescriptions
In a recent congressional hearing, Rep. Dan Crenshaw again pleaded his case for the advancement of psychedelic use in the mentally ill. The matter at
Cybin Inc. (NEO:CYBN / NYSE American:CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, today announced that
Lucy Scientific Discovery Inc. (NASDAQ: LSDI), an innovator in psychotropic drug development, proudly announces the launch of “Twilight” – a blend of Amanita and Reishi